[U] “Swamp: Fear Not, Thy Depths Shall Not Be… Drained” Dept. — Merck Hires HHS Sec. Dr. Price’s Former Chief Of Staff — To Lobbyist Slot

Ahem. Well. So much for “draining that swamp,” right? [Update: My counter tells me this is post number 4,200 on this site.]

Despite 45’s various pledges about getting tough on pharma pricing — it turns out that all the usual suspects are now all hiring as a lobbyist, the firm that houses the former chief of staff to HHS Secretary Price (Trump’s main man!) — to lobby on reimbursement issues, among other topics.

This is why federal disclosure laws are so critical: at least we the people may see what is being done, in our name.

Moreover, this is but one tiny example — proving a general narrative — 45 is a. . . fraud. This junk is rolling out, all over DC.

And to be clear, Merck is just playing the game in the usual smart way. No dart thrown, here — or at Amgen or PhRMA — they’d be fools not to have this guy as their mouth piece in DC. And I am sure he’s a very capable ethical advocate. It is just an endless revolving door game, in truth. . . .

From the LD-1 Kenilworth had filed last month, then:

. . . .Matt McGinley — Covered Positions: Chief of Staff, Rep. Tom Price; Chief of Staff, Republican Policy Committee; DCOS & LD, Rep. Brian Kerns. . . .

UPDATED: 04.17.2017 — Merck now reports that the $20,000 it spend in Q1 2017 with the lobbying firm was for “. . .Tax Reform: International tax provisions as it relates to the taxation of income derived from intangible property. . . .” We will watch the full reporting cycle this year to see whether that remains — as the limit of the firm’s engagement. . . . [End, Updated portion.]

Ahh. . . it smells like. . . swamp, to me. 45 has not a snowball’s chance in the River Styx of ending this sort of coziness [my cynical side says it is all intended, all the bluster was for the suckers-show, only]. Hilarious. Even so, I find I cannot stop. . . grinning (on this clear azure morning — old friends are the best friends!), despite this rather cynical turn of events, on drug and biologic price policy setting. Onward!

नमस्ते

Advertisements

There are no comments on this post.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: